|
Indian Pediatr 2018;55: 614 |
|
Vitamin D: For Whom and How Much?
|
Anju Seth 1
and Vijayalakshmi Bhatia2
Department of 1Pediatrics, LHMC, New Delhi;
and 2Department of Endocrinology, SGPGIMS, Lucknow,
Uttar Pradesh; India.
Email: [email protected]
|
We read with interest the recommendations on prevention and treatment of
vitamin D and calcium deficiency [1]. While welcoming this article that
served the need of the hour, we have the following comments.
Our first observation pertains to risk of vitamin D
toxicity likely to be associated with use of bolus doses of vitamin D
for treatment of rickets in infants. The authors recommend 60,000 IU
vitamin D weekly for 6 weeks as treatment for rickets in all infants >3
months of age. They have quoted Endocrine Society USA guidelines [2] for
the same, which in fact recommend a dose of 50,000 IU weekly. This
recommendation was based on a single study [3] that was underpowered,
with a final sample size less than estimated. Hypervitaminosis was
observed in 3/35 infants enrolled in that study. A rapid rise in vitamin
D levels with one- or two-monthly bolus doses of vitamin D in infants
has also been reported by others [4,5]. Thus, there is no evidence that
60,000 IU vitamin D weekly for 6 weeks is a safe regimen in infancy,
while there are definite pointers that this may be associated with serum
vitamin D exceeding safety limits, especially since lower doses are
known to heal rickets [6]. Moreover, the recommendation of a Tolerable
Upper Limit of rather large doses of 1000 to 3000 and 4000 units daily
[1], presumably indefinitely, has no supporting literature and may be
toxic [7].
Our second observation pertains to preventive
supplementation. While there is sufficient Global and Indian literature
to recommend universal pharmacological supplementation for all infants
not deriving their intake from formula milk, there is a scarcity of
studies between 3 and 10 years age. This is an age group where we do not
usually encounter nutritional rickets. Thus, recommending vitamin D
intake to all children in this age group is not backed by evidence.
Adolescents (particularly girls) and pregnant women have been documented
to have high prevalence of deficiency in studies from Northern and
Central India, and deserve supplementation, but much more data are
needed from the Southern and coastal states and the North-East of our
country, in all age groups. Universal recommendation of supplementing
all children and adolescents, therefore, lacks evidence, apart from
being impractical.
References
1. Indian Academy of Pediatrics ‘Guideline for
Vitamin D and Calcium in Children’ Committee, Khadilkar A, Khadilkar V,
Chinnappa J, Rathi N, Khadgawat R, et al. Prevention and
Treatment of Vitamin D and Calcium Deficiency in Children and
Adolescents: Indian Academy of Pediatrics (IAP) Guidelines. Indian
Pediatr. 2017;54:567-73.
2. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon
CM, Hanley DA, Heaney RP, et al. Evaluation, Treatment, and
Prevention of Vitamin D Deficiency: An Endocrine Society Clinical
Practice Guideline. J Clin Endocrinol Metab. 2011;7:1911-30.
3. Gordon CM, Williams AL, Feldman HA, May J,
Sinclair L, Vasquez A, et al. Treatment of hypovitaminosis D in
infants and toddlers. J Clin Endocrinol Metab. 2008;7:2716-21.
4. Huynh J, Lu T, Liew D, Doery JC, Tudball R, Jona
M, et al. Vitamin D in newborns. A randomised controlled trial
comparing daily and single oral bolus vitamin D in infants. J Paediatr
Child Health. 2017;2:163-9.
5. Shakiba M, Sadr S, Nefei Z, Mozaffari-Khosravi H,
Lotfi MH, Bemanian MH. Combination of bolus dose vitamin D with routine
vaccination in infants: A randomised trial. Singapore Med J.
2010;51:440-5.
6. Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD,
Ozono K, et al. Global Consensus Recommendations on Prevention
and Management of Nutritional Rickets. Horm Res Paediatr. 2016;2:83-106.
7. Vanstone MB, Oberfield SE, Shader L, Ardeshirpour
L, Carpenter TO. Hypercalcemia in children receiving pharmacologic doses
of vitamin D. Pediatrics. 2012;4:e1060-3.
|
|
|
|